Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 1/2003

01-03-2003

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway?

Authors: Ben Davidson, Iris Goldberg, Walter H. Gotlieb, Juri Kopolovic, Bjørn Risberg, Gilad Ben-Baruch, Reuven Reich

Published in: Cancer and Metastasis Reviews | Issue 1/2003

Login to get access
Metadata
Title
Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway?
Authors
Ben Davidson
Iris Goldberg
Walter H. Gotlieb
Juri Kopolovic
Bjørn Risberg
Gilad Ben-Baruch
Reuven Reich
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers
Published in
Cancer and Metastasis Reviews / Issue 1/2003
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1023/A:1022272204045

Other articles of this Issue 1/2003

Cancer and Metastasis Reviews 1/2003 Go to the issue

OriginalPaper

Prostate cancer in black and white Americans

OriginalPaper

Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands

OriginalPaper

Socioeconomic factors and breast cancer in black and white Americans

OriginalPaper

Introduction: Cancer and health disparities

OriginalPaper

Chronic inflammation as inductor of pro-cancer microenvironment: Pathogenesis of dysregulated feedback control

OriginalPaper

Myeloma and race: A review of the literature
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits